Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/19/22
End: 10/31/22
Due: 10/31/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb) | NCT05411575 | 4Living Biotech | user2@example.com | None | 2022-07-19 | 2022-10-31 | 2023-10-31 | - | - | 2025-07-14 |